TIMOPTIC
What it isBeta-receptor antagonist eye drop that reduces aqueous production; open-angle glaucoma.
Why this oneThe benchmark ocular beta blocker, it is inexpensive and adds effectively to a prostaglandin analog.
What limits itEye drops can still cause bradycardia and bronchospasm; use punctal occlusion and avoid in asthma or heart block.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypertension | Adults | 10 mg BID | 20-40 mg/day | 60 mg/day divided BID |
| Myocardial infarction (post-MI prophylaxis) | Adults | 10 mg BID | 10 mg BID | |
| Migraine prophylaxis | Adults | 10 mg BID | 20 mg/day (may give QD) | 30 mg/day divided |
Titration For hypertension, at least 7 days between dose increases
Renal Undefined
Hepatic Undefined
Pregnancy No adequate human studies; use only if potential benefit justifies potential fetal risk
Lactation Undefined
NO BOXED WARNINGS
Principal riskSystemic beta blockade from eye drops: bradycardia and bronchospasm
Cost, est. cash$200–$1,000/month
Generic entry2016
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Open Timolol in the interactive console ↗

